Bucheon, South Korea

Yoon-Jong Lee

This inventor holds 1 USPTO granted patent. Top assignee: National Cancer Center. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoon-Jong Lee. Retrieved from https://idiyas.com/inventor/yoon-jong-lee-b3ev15cu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoon-Jong Lee: Innovator in Molecular Imaging

Introduction

Yoon-Jong Lee is a prominent inventor based in Bucheon, South Korea. He has made significant contributions to the field of molecular imaging, particularly in the diagnosis of diseases. His innovative approach utilizes advanced techniques to enhance the accuracy of disease detection.

Latest Patents

Yoon-Jong Lee holds a patent for a "Method for diagnosing disease using adenovirus harboring trans-splicing ribozyme by molecular imaging." This patent discloses a composition for molecular imaging that comprises a trans-splicing ribozyme coupled with an imaging reporter gene. The trans-splicing ribozyme specifically targets a gene associated with a disease, providing a novel method for molecular imaging.

Career Highlights

Yoon-Jong Lee is affiliated with the National Cancer Center, where he applies his expertise in molecular imaging to advance cancer research and diagnostics. His work is instrumental in developing innovative solutions that can potentially improve patient outcomes.

Collaborations

Yoon-Jong Lee collaborates with notable colleagues, including Yeon-Su Lee and Haeng-Im Jung. Their combined efforts contribute to the advancement of research in molecular imaging and disease diagnosis.

Conclusion

Yoon-Jong Lee's contributions to molecular imaging and disease diagnosis exemplify the impact of innovative thinking in the medical field. His work continues to pave the way for advancements that can enhance diagnostic accuracy and improve healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…